Compass Therapeutics, Inc. · NASDAQ:CMPX

Orbimed Advisors LLC reported a 11.00% stake in Compass Therapeutics, Inc. (Schedule 13D/A)

Event Apr 9, 2024 · Filed Apr 11, 2025

Orbimed Advisors LLC reported a 11.00% stake in Compass Therapeutics, Inc., 15,219,994 shares, with active intent on Apr 9, 2024. Filed Apr 11, 2025 (Schedule 13D/A).

Stake
11.00%
Shares
15,219,994
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC11.00%15,219,994
ORBIMED CAPITAL GP V LLC11.00%15,219,994
OrbiMed Genesis GP LLC0%0
ORBIMED CAPITAL LLC0%0

Source

View original at SEC

Related